KLOW is a four-component research peptide blend combining GHK-Cu, BPC-157, TB-500 and KPV in a single lyophilised formulation.

Building on the three-component GLOW concept, KLOW introduces KPV as an additional peptide of interest in inflammatory and epithelial research. Together, the four components are studied individually across areas involving tissue remodelling, extracellular-matrix biology, cellular migration and inflammatory signalling.

What is KLOW?

KLOW combines four research peptides with complementary areas of scientific interest:

GHK-Cu
A naturally occurring copper-binding tripeptide extensively researched for its relationship with collagen synthesis, fibroblast activity, extracellular-matrix remodelling, skin biology, antioxidant activity and cellular signalling.

BPC-157
A synthetic 15-amino-acid peptide investigated primarily in preclinical models involving tissue repair, angiogenesis, tendon and connective-tissue recovery, gastrointestinal protection and inflammatory pathways.

TB-500
A peptide associated with thymosin beta-4 research and investigated for its relationship with actin regulation, cellular migration, angiogenesis and tissue-remodelling processes.

KPV
A small tripeptide consisting of Lysine-Proline-Valine and derived from the C-terminal region of alpha-MSH. KPV has attracted research interest for its effects on inflammatory signalling, including pathways involving NF-κB and inflammatory cytokines.

Why Combine Them?

The research concept behind KLOW is to bring together several distinct biological pathways within one formulation.

GHK-Cu provides the extracellular-matrix and collagen research component.

BPC-157 contributes to research involving tissue repair and angiogenic signalling.

TB-500 adds an area of investigation involving cell migration and tissue remodelling.

KPV expands the formulation toward inflammatory and epithelial signalling research.

This makes KLOW particularly interesting for laboratory research involving:

• Tissue regeneration and remodelling
• Skin and extracellular-matrix biology
• Collagen-related pathways
• Fibroblast activity
• Connective-tissue research
• Cellular migration
• Angiogenesis
• Inflammatory signalling
• Oxidative-stress pathways
• Epithelial and gastrointestinal research

KLOW 80mg

A commonly used KLOW research formulation contains:

GHK-Cu – 50mg
BPC-157 – 10mg
TB-500 – 10mg
KPV – 10mg

Total peptide content: 80mg